BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2464468)

  • 21. Carbimazole induced ANCA positive vasculitis.
    Pandey S; Kushwaha RS; Mehndiratta P; Mehndiratta MM
    J Assoc Physicians India; 2008 Oct; 56():801-3. PubMed ID: 19263707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
    Lizcano F; Salvador J
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
    Ford HC; Feek CM; Delahunt JW
    N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute cholestatic hepatitis along with agranulocytosis: a rare side effect of carbimazole.
    Jain K; Chakrapani M; Smitha K
    Ann Afr Med; 2010; 9(2):102-4. PubMed ID: 20587933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacology and dosage of thyrostatic drugs].
    Passath A; Leb G; Warnkross H
    Acta Med Austriaca; 1987; 14(3-4):72-4. PubMed ID: 2447738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thyrostatic therapy in patients with liver cirrhosis].
    Rink C; Klaua M; Mertens E; Schneider G; Nilius R
    Z Gesamte Inn Med; 1985 May; 40(10):300-2. PubMed ID: 2412355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dosed antithyroid drug monotherapy in hyperthyroidism.
    Seidel C; Ziegelitz D; Frenzel R; Dittmer T
    Exp Clin Endocrinol; 1984 Mar; 83(1):73-86. PubMed ID: 6539216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphadenomegaly associated with carbimazole.
    Atkinson M
    J Small Anim Pract; 2008 Aug; 49(8):426. PubMed ID: 18768076
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
    Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
    Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Possible teratogenic effects of thiamazole].
    Ozgen HM; Reuvers-Lodewijks WE; Hennekam RC
    Ned Tijdschr Geneeskd; 2006 Jan; 150(2):101-4. PubMed ID: 16440566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2005 Sep; 77(3):139-44. PubMed ID: 16151671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term treatment of thyrotoxicosis with antithyroid drugs].
    Wahlberg P
    Nord Med; 1970 Mar; 83(12):353-6. PubMed ID: 4193207
    [No Abstract]   [Full Text] [Related]  

  • 35. Carbimazole-induced agranulocytosis--a report of 2 recent cases.
    Tavintharan S; Rajasoorya C; Chew LS
    Singapore Med J; 1997 Sep; 38(9):386-7. PubMed ID: 9407764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
    Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D
    J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism.
    Chen DY; Jing J; Schneider PF; Chen TH
    Nucl Med Commun; 2009 Feb; 30(2):160-8. PubMed ID: 19194213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatotoxicity from antithyroid drugs.
    Vitug AC; Goldman JM
    Horm Res; 1985; 21(4):229-34. PubMed ID: 4007783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse effects of thyroid hormone preparations and antithyroid drugs.
    Bartalena L; Bogazzi F; Martino E
    Drug Saf; 1996 Jul; 15(1):53-63. PubMed ID: 8862963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives.
    Karras S; Tzotzas T; Krassas GE
    Hormones (Athens); 2009; 8(4):254-7. PubMed ID: 20058397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.